Oncotarget

ISSN: 1949-2553
Verlag: Impact Journals



Publikationen

Go to first page Go to previous page 1 von 8 Go to next page Go to last page

Heftnummer: 41, Band: 9, Seitenbereich: 26543-26555
Characterization and diagnostic application of genomic NPM-ALK fusion sequences in anaplastic large-cell lymphoma (2018)
Krumbholz M, Woessmann W, Zierk J, et al.

Heftnummer: 3, Band: 9, Seitenbereich: 3605-3618
Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic "dual-hit" option (2018)
Dietrich P, Freese K, Mahli A, et al.

Heftnummer: 17, Band: 9, Seitenbereich: 13125-13138
IL-21 modulates memory and exhaustion phenotype of T-cells in a fatty acid oxidation-dependent manner (2018)
Loschinski R, Böttcher M, Stoll A, et al.

Heftnummer: 48, Band: 9, Seitenbereich: 28903-28909
Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patients (2018)
Kirchberger MC, Moreira A, Erdmann M, et al.

Heftnummer: 12, Band: 9, Seitenbereich: 10445-10456
Selenium-binding protein 1 is down-regulated in malignant melanoma (2018)
Schott M, de Jel MM, Engelmann JC, et al.

Heftnummer: 12, Band: 9, Seitenbereich: 10402-10416
Serum levels of miR-320 family members are associated with clinical parameters and diagnosis in prostate cancer patients (2018)
Lieb V, Weigelt K, Scheinost L, et al.

Heftnummer: 40, Band: 9, Seitenbereich: 25935-25945
Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening (2018)
Rinaldetti S, Rempel E, Worst TS, et al.

Heftnummer: 39, Band: 8, Seitenbereich: 64670-64684
Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci (2017)
Glubb DM, Johnatty SE, Quinn MCJ, et al.


Zuletzt aktualisiert 2019-25-04 um 14:43